Grand Rounds Nation
Grand Rounds Nation

Immunotherapy for Non-small Cell Lung Cancer: A Brief Review

July 11, 201614 min
Guest: Everett E. Vokes, MD In this Grand Rounds recorded live at ASCO, Dr. Vokes introduces the concept of T-cell blockade and Checkpoint Inhibition as rationale for considering use of anti-PD-1 anti-CTLA-4 agents in the management of non-small cell lung cancer (NSCLC). Also discussed will be data reflective of the use of tumor biomarkers when selecting treatment strategies for patients with NSCLC, specifically those with elevated expression of PD-L1.

Chat About Immunotherapy for Non-small Cell Lung Cancer: A Brief Review